| Cascading network failure across the Alzheimer’s disease spectrum DT Jones, DS Knopman, JL Gunter, J Graff-Radford, P Vemuri, BF Boeve, ... Brain 139 (2), 547-562, 2016 | 479 | 2016 |
| Consensus classification of posterior cortical atrophy SJ Crutch, JM Schott, GD Rabinovici, M Murray, JS Snowden, ... Alzheimer's & Dementia 13 (8), 870-884, 2017 | 474 | 2017 |
| Longitudinal tau PET in ageing and Alzheimer’s disease CR Jack Jr, HJ Wiste, CG Schwarz, VJ Lowe, ML Senjem, P Vemuri, ... Brain 141 (5), 1517-1528, 2018 | 371 | 2018 |
| New insights into atypical Alzheimer's disease in the era of biomarkers J Graff-Radford, KXX Yong, LG Apostolova, FH Bouwman, M Carrillo, ... The Lancet Neurology 20 (3), 222-234, 2021 | 295 | 2021 |
| Widespread brain tau and its association with ageing, Braak stage and Alzheimer’s dementia VJ Lowe, HJ Wiste, ML Senjem, SD Weigand, TM Therneau, BF Boeve, ... Brain 141 (1), 271-287, 2018 | 271 | 2018 |
| Associations of amyloid, tau, and neurodegeneration biomarker profiles with rates of memory decline among individuals without dementia CR Jack, HJ Wiste, TM Therneau, SD Weigand, DS Knopman, MM Mielke, ... Jama 321 (23), 2316-2325, 2019 | 248 | 2019 |
| Age at symptom onset and death and disease duration in genetic frontotemporal dementia: an international retrospective cohort study KM Moore, J Nicholas, M Grossman, CT McMillan, DJ Irwin, L Massimo, ... The Lancet Neurology 19 (2), 145-156, 2020 | 236 | 2020 |
| Prevalence of biologically vs clinically defined Alzheimer spectrum entities using the National Institute on Aging–Alzheimer’s Association research framework CR Jack, TM Therneau, SD Weigand, HJ Wiste, DS Knopman, P Vemuri, ... JAMA neurology 76 (10), 1174-1183, 2019 | 226 | 2019 |
| Tau, amyloid, and cascading network failure across the Alzheimer's disease spectrum DT Jones, J Graff-Radford, VJ Lowe, HJ Wiste, JL Gunter, ML Senjem, ... Cortex 97, 143-159, 2017 | 192 | 2017 |
| Age, vascular health, and Alzheimer disease biomarkers in an elderly sample P Vemuri, TG Lesnick, SA Przybelski, DS Knopman, VJ Lowe, ... Annals of neurology 82 (5), 706-718, 2017 | 186 | 2017 |
| AV‐1451 tau and β‐amyloid positron emission tomography imaging in dementia with Lewy bodies K Kantarci, VJ Lowe, BF Boeve, ML Senjem, N Tosakulwong, TG Lesnick, ... Annals of neurology 81 (1), 58-67, 2017 | 182 | 2017 |
| Dementia with Lewy bodies: basis of cingulate island sign J Graff-Radford, ME Murray, VJ Lowe, BF Boeve, TJ Ferman, ... Neurology 83 (9), 801-809, 2014 | 176 | 2014 |
| White matter hyperintensities: relationship to amyloid and tau burden J Graff-Radford, EM Arenaza-Urquijo, DS Knopman, CG Schwarz, ... Brain 142 (8), 2483-2491, 2019 | 163 | 2019 |
| Pattern of brain atrophy rates in autopsy-confirmed dementia with Lewy bodies Z Nedelska, TJ Ferman, BF Boeve, SA Przybelski, TG Lesnick, ME Murray, ... Neurobiology of aging 36 (1), 452-461, 2015 | 157 | 2015 |
| Vascular imaging abnormalities and cognition: mediation by cortical volume in nondemented individuals: atherosclerosis risk in communities-neurocognitive study DS Knopman, ME Griswold, ST Lirette, RF Gottesman, K Kantarci, ... Stroke 46 (2), 433-440, 2015 | 153 | 2015 |
| Performance of plasma phosphorylated tau 181 and 217 in the community MM Mielke, JL Dage, RD Frank, A Algeciras-Schimnich, DS Knopman, ... Nature medicine 28 (7), 1398-1405, 2022 | 148 | 2022 |
| The bivariate distribution of amyloid-β and tau: relationship with established neurocognitive clinical syndromes CR Jack Jr, HJ Wiste, H Botha, SD Weigand, TM Therneau, DS Knopman, ... Brain 142 (10), 3230-3242, 2019 | 145 | 2019 |
| Alzheimer’s association ISTAART atypical Alzheimer’s disease and associated syndromes professional interest area SJ Crutch, JM Schott, GD Rabinovici, M Murray, JS Snowden, ... Consensus classification of posterior cortical atrophy. Alzheimers Dement 13 …, 2017 | 135 | 2017 |
| Comparison of plasma phosphorylated tau species with amyloid and tau positron emission tomography, neurodegeneration, vascular pathology, and cognitive outcomes MM Mielke, RD Frank, JL Dage, A Jeromin, NJ Ashton, K Blennow, ... JAMA neurology 78 (9), 1108-1117, 2021 | 134 | 2021 |
| Evaluation of amyloid protective factors and Alzheimer disease neurodegeneration protective factors in elderly individuals P Vemuri, DS Knopman, TG Lesnick, SA Przybelski, MM Mielke, ... JAMA neurology 74 (6), 718-726, 2017 | 129 | 2017 |
Prashanthi VemuriMayo ClinicVerified email at mayo.edu
